Evolent Health Inc (EVH) concluded trading on Wednesday at a closing price of $9.97, with 6.96 million shares of worth about $69.37 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -54.10% during that period and on January 15, 2025 the price saw a loss of about -10.82%. Currently the company’s common shares owned by public are about 115.01M shares, out of which, 112.74M shares are available for trading.
Stock saw a price change of -16.64% in past 5 days and over the past one month there was a price change of -12.54%. Year-to-date (YTD), EVH shares are showing a performance of -11.38% which decreased to -68.33% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $10.53 but also hit the highest price of $35.00 during that period. The average intraday trading volume for Evolent Health Inc shares is 2.63 million. The stock is currently trading -12.76% below its 20-day simple moving average (SMA20), while that difference is down -23.82% for SMA50 and it goes to -55.58% lower than SMA200.
Evolent Health Inc (NYSE: EVH) currently have 115.01M outstanding shares and institutions hold larger chunk of about 110.96% of that.
The stock has a current market capitalization of $1.16B and its 3Y-monthly beta is at 1.46. It has posted earnings per share of -$0.91 in the same period. It has Quick Ratio of 1.04 while making debt-to-equity ratio of 0.79. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EVH, volatility over the week remained 10.34% while standing at 5.89% over the month.
Analysts are in expectations that Evolent Health Inc (EVH) stock would likely to be making an EPS of 0.05 in the current quarter, while forecast for next quarter EPS is 0.22 and it is 0.92 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.1 which is 0.13 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of 0.23 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -14.31% while it is estimated to increase by 36.04% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Needham on January 10, 2025 offering a Buy rating for the stock and assigned a target price of $15 to it. Coverage by BTIG Research stated Evolent Health Inc (EVH) stock as a Buy in their note to investors on December 03, 2024, suggesting a price target of $29 for the stock. On November 08, 2024, Stephens Downgrade their recommendations, while on October 11, 2024, KeyBanc Capital Markets Initiated their ratings for the stock with a price target of $35. Stock get a Buy rating from Truist on August 09, 2024.
